OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6

Ying Zhao1,2, Jing Ruan3, Zhongding Li1

  • 1Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.

Abstract

Insights

OTUB1 deubiquitinates and stabilizes CCN6, a tumor suppressor in breast cancer. OTUB1 downregulation in breast cancer promotes tumor progression by reducing CCN6 levels.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • CCN6 is a critical matricellular protein regulating breast cancer tumorigenesis.
  • Mechanisms controlling CCN6 protein levels, particularly via ubiquitination, are not well understood.

Purpose of the Study:

  • To investigate the role of deubiquitinating enzymes (DUBs) in regulating CCN6 protein levels.
  • To elucidate the specific DUB responsible for CCN6 regulation and its mechanism in breast cancer.

Main Methods:

  • Screening assay to identify DUBs targeting CCN6.
  • Biochemical assays to define the OTUB1-CCN6 interaction and mechanism.
  • Cellular and in vivo models to assess the functional impact of OTUB1-CCN6 interaction.
  • Immunohistochemistry and Western blot to analyze OTUB1 and CCN6 expression in human breast cancer tissues.

Main Results:

  • OTUB1 was identified as a DUB that directly interacts with CCN6.
  • OTUB1 inhibits K48-linked ubiquitination and proteasomal degradation of CCN6 in a non-canonical manner.
  • OTUB1 downregulation in breast cancer leads to decreased CCN6 levels, enhancing cancer cell migration, proliferation, and viability.
  • OTUB1 expression inversely correlates with breast cancer progression.

Conclusions:

  • OTUB1 is a novel deubiquitinating enzyme that stabilizes the tumor suppressor CCN6 in breast cancer.
  • OTUB1 acts as a potential therapeutic target for breast cancer treatment by restoring CCN6 levels.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.0K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K